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1. introduction 
It was previously found that some a-IV-alkyl 
derivatives of L-glutamine markedly inhibit the growth 
of glutamine-requiring strains of hemolytic streptococci 
[l] and of experimental mouse tumours [2] . It was 
also found that such compounds inhibit ovine brain 
and rat liver glutamine synthetase in vitro [3,4] . On 
the other hand, they could substitute for glutamine 
in the synthesis of NAD by rat liver preparations [5]. 
It was recently observed that carbobenzoxy (Cbz) de- 
rivatives of various amino acids inhibit several enzyme 
systems connected with the metabolism of glutamine 
and asparagine [5-81 as well as the growth of some 
transplantable murine tumours [9, lo] . In view of 
these findings it was of interest to study the effect of 
cr-IV-alkyl derivatives of Lglutamine and of Cbz-amino 
acids on purine biosynthesis. The present paper deals 
with this problem. 
2. Materials and methods 
cr-IV-Alkyl derivatives of L-glutamine were prepared 
as previously described [ 1,3, 1 l] . They contained less 
than one percent free glutamine as tested chromato- 
graphically and by the colour reaction with aqueous 
ninhydrin. The preparation of Cbz-/3-N-benzyl-L- 
asparagine and Cbz-D,L-homocysteine (5 mg/ml) and 
will be described elsewhere. All other Cbz-derivatives 
and L-glutamine were purchased from Fluka A.G., 
Buchs (Switzerland). D-Ribose-5-phosphate (Naz), 
North-Holland Publishing Company - Amsterdam 
ATP and D-3-phosphoglyceric acid (Na) were from 
Sigma Chemical Company, St.Louis, Missouri. 
H14COONa (10.8 mCi/nmole) was obtained from 
Radiochemical Centre, Amersham (England). 
2.1, Enzyme preparations 
Homogenates of pigeon livers were prepared by 
the procedure of Flanks and Lukens [ 121 . After the 
first centrifugation at 100,000 g in a Spinco model L 
centrifuge for 30 min, the supernatant fluid was 
lyophilized with D,L-homocysteine (5 mg/ml) and 
kept at -22”. For enzymatic experiments the lyophi- 
lized preparations were dissolved in the homogenizing 
medium (50 mg/ml) described by Franks and Lukens 
[ 121 and dialized against this medium for 16- 18 hr 
at 4”. 
2.2. Assay procedure 
The reaction mixture contained (in nmoles/l.5 
ml): phosphate buffer, pH 7.4,50; NaHCOs, 50 
(pH adjusted to 7.4 by bubbling CO2 through); 
MgCl,, 5; glycine, 5; Gaspartate, 5; ATP, 2; D,L- 
homocysteine, 5; D-riboseJ-phosphate, 5; D-3- 
phosphoglycerate, 28; Hr4COONa (20,000 cpm/ 
nmole), 5; L-glutamine and various inhibitors, as 
indicated in the tables; enzyme (dialized as described 
above), 50 mg. Incubation was carried out at 38” for 
60 min, terminated with 0.2 ml of 50% trichloro- 
acetic acid and the tubes cooled and centrifuged. 
Aliquots (0.8 ml) of the supernatants were evaporated 
to dryness at 130’ after addition of 0.4 ml 6 N HCl. 
6 N HCI (0.2 ml) was added again and the solutions 
were again evaporated to dryness. The solid residue was 
dissolved in 0.2 ml water and was then diluted to 
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Table 1 
Effect of a WV-alkyl derivatives of L-glutamine on purine biosynthesis. 
March 1971 
L-Glutamine derivatives Formate-‘4C incorporated 
R Inhibition 
Radioactive hypoxanthine 
added (pmoles) @moles) formed @moles)* 
% Inhibition 
None 105 
wV-Ethyl (SO) 63 
@N-Ethyl (100) 32 
cll-N-Propyl (SO) 65 
WV-Propyl (100) 39 
WV-Butyl(50) 74 
a-N-Butyl (100) 60 
(Y-N-Amy1 (SO) 66 
@N-Amy1 (100) 47 
(Y, a’-N-Dimethyl (100) 14 
._ 
40 
69 
38 
63 
30 
43 
37 
55 
88 
55 
38 
62 
42 
66 
57 
62 
51 
88 
._ 
38 
57 
30 
52 
25 
35 
30 
42 
All reaction mixtures contained 10 wmoles of L-glutamine. 
* Hypoxanthine was determined chromatographically in solvent 1. 
10 ml with scintillation fluid prepared according to 
Brey [ 131. Radioactivity was measured in Packard, 
model 3320, scintillation counter. Blanks without 
enzyme or L-glutamine were very low and were sub- 
tracted. 
2.3. Determination of radioactive hypoxanthine by 
paper chromatography 
Aliquots of the reaction mixtures were evaporated as 
above, but the evaporation was carried out at 100” 
(under these conditions purine nucleotides are hy- 
drolized to free bases without significant damage to 
the latter [ 141). The residues were dissolved in 0.1 ml 
water and aliquots were taken for chromatography. 
Descending chromatography was carried out on 
Whatman no. 3 paper, using two different solvents - 
solvent 1: butanol sat. with water (NH3 atmosphere); 
solvent 2: butanol-formic acid-water (77: 10: 13, 
v/v) [IS] - and run for 22-24 hr. At the end of this 
time the chromatogram was dried, the place of the 
markers was located by the use of a UV lamp and the 
radioactive material was detected with a Packard, 
model 7201, radiochromatogram scanner. Most of 
the radioactivity obtained with the two different 
solvents corresponds to hypoxanthine. The area of 
the peaks were cut out, put into 10 ml scintillation 
fluid prepared according to Brey [ 131, and the radio- 
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activity was estimated in a Packard, model 3320, 
scintillation counter. 
3. Results and discussion 
As can be seen from table 1, a-N-alkyl derivatives 
of L-glutamine inhibit the incorporation of radio- 
active formate and hypoxanthine formation by pi- 
geon liver preparation. The most effective inhibition 
was given by @-N-ethyl and ol_N-propyl-L-glutamine. 
Under the same condition a-N-dimethyl-L-glutamine 
showed no inhibition. When higher amounts of L- 
glutamine were added to the incubation mixtures 
(table 2), the inhibition by a-N-ethyl and a+&propyl- 
L-glutamine was markely diminished. No significant 
decrease of the extent of inhibition was observed 
when the concentration of glycine or L-aspartate in 
the reactions mixtures was increased. 
As can be seen from table 3, Cbz-L-glutamine and 
Cbz-derivatives of other aliphatic amino acids strong- 
ly inhibit purine biosynthesis. All these compounds 
inhibit approximately to the same extent. On the 
other hand, Cbz-amino acids with an additional 
aromatic group (e.g. Cbz-L-phenylalanine, CbzS- 
benzyl-L-cysteine are much stronger inhibitors than 
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Table 2 
Effect of high concentrations of L-glutamine on the 
inhibition of purine biosynthesis by (Y-N-alkyl derivatives of
L-glutamine. 
L-Glutamine L-Glutamine Formate-14C % Inhi- 
added (pmoles) derivative added incorporated bition 
(nmoles) 
(10) None 195 .~ 
(200) None 200 ._ 
(10) @N-Ethyl 59 70 
(200) &N-Ethyl 115 41 
(10) Cr-N-Propyl 86 56 
(200) (Y-N-Propyl 136 30 
Cbz-derivatives of aliphatic amino acids. The most 
effective inhibitor of this kind was CbzS-benzyl-L- 
cysteine. There was no difference in inhibition by 
Cbz-L- or D, L-phenylalanine. An increase of the 
concentration of either L-glutamine, glycine or L- 
aspartate in the reaction mixture did not affect the 
inhibition by Cbz-L-glutamine, Cbz-glycine, Cbz-L- 
aspartic acid and Cbz-L-phenylalanine. 
The effect of a-N-alkyl derivatives of L-glutamine 
and Cbz-derivatives of amino acids on the biosynthesis 
of purine by chicken liver preparations was also studied 
Essentially the same inhibitory effects as with pigeon 
liver preparation were obtained. 
As to the mechanism of the inhibition, the simi- 
arity of the ar-IV-alkyl derivatives of glutamine and 
the fact that the inhibition by these derivatives 
Table 3 
Effect of Cbz d,erivatives of amino acids on purine biosynthesis. 
Cbz-derivatives added Formate-14C 
(firmoles) incorporated (nmoles) 
None 182 
Cbz-L-glutamine (100) 5s 
Cbz-L-asparagine (20) 152 
Cbz-L-asparagine (100) 49 
Cbz-p-N-benzyl-L-asparagine (20) 100 
Cbz-L-alanine (20) 115 
Cbz-L-alanine (100) 22 
Cbz-L-phenylalanine (20) 14 
None 112 
Cbz-L-aspartic acid (100) 35 
Cbz glycine (20) 78 
Cbz glycine (100) 43 
Cbz-D, L-phenylglycine (10) 62 
Cbz-D, L-phenylglycine (20) 7 
Cbz-D, L-phenylalanine (10) 62 
Cbz-L-phenylalanine (10) 60 
Cbz-L-tryptophan (10) 44 
CbzS-benzyl-L-cysteine (5) 62 
CbzS-benzyl-L-cysteine (10) 0 
% Inhibition 
Radioactive hypoxanthine 
formed (nmoles)* 
_ 
._ 150 
70 53 
17 120 
73 47 
45 75 
37 97 
88 30 
92 15 
.- 91 
69 34 
30 66 
62 30 
45 52 
94 9 
45 52 
47 49 
61 32 
45 46 
100 0 
‘X Inhibition 
._ 
65 
20 
69 
50 
35 
80 
90 
._ 
63 
27 
67 
43 
90 
43 
46 
65 
49 
100 
All reaction mixtures contained 10 pmoles of L-glutamine 
* Hypoxanthine was determined chromatographically in solvent 1. 
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diminished with increasing glutamine concentration 
may indicate that they act as structural analogs of 
glutamine, On the other hand, it may be assumed that 
the mechanism of inhibition by Cbz-amino acids is 
similar to that suggested for the inhibition of other 
enzyme systems by such compounds [7] . The aro- 
matic groups of the inhibitors are thought. to bind 
to the enzyme molecule by hydrophobic interactions 
causing inhibition by conformational changes. It was 
recently found [16] that some Cbz-derivatives of 
amino acids strongly inhibit the proteolytic activity 
of trypsin and chymotrypsin, hence the inhibitory 
effect of such compounds is not restricted to enzymes 
connected with the metabolism of glutamine and as- 
paragine. Purine biosynthesis is the result of action of 
a multitude of enzymes and it is therefore difficult to 
decide which is inhibited by the Cbz-compounds. An 
investigation of the effect of such compounds on the 
isolated enzymes participating in purine biosynthesis 
therefore appears desirable. 
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